Development and validation of a multidisciplinary risk assessment scale for immune checkpoint inhibitor-associated myocarditis
ObjectiveTo develop a risk assessment scale for immune checkpoint inhibitor (ICI)-associated myocarditis based on multidisciplinary collaboration, and to evaluate its diagnostic performance. MethodsBased on multidisciplinary cooperation, integrating clinical experience from oncology and cardiology,...
Saved in:
| Main Authors: | Yanan DAI, Yuan LIU, Yuchen XU, Qingqing CAI, Yan WANG, Yuhong ZHOU, Leilei CHENG, Junbo GE |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2025-08-01
|
| Series: | Zhongguo Linchuang Yixue |
| Subjects: | |
| Online Access: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250469 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01) -
Comparison of the diagnostic and prognostic value of criteria for immune checkpoint inhibitor related myocarditis
by: Milagros Pereyra Pietri, et al.
Published: (2025-03-01) -
Predictors of Long‐Term Survival in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
by: Nikhil Dubey, et al.
Published: (2025-07-01) -
A Blind Spot in Imaging: Immune Checkpoint Inhibitor-Induced Myocarditis with Negative Cardiac MRI
by: Lubna Alnatour, et al.
Published: (2025-05-01) -
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
by: Le Xu, et al.
Published: (2025-12-01)